| 19-1381 |
BioDelivery Sciences International, Inc. v. Aquestive Therapeutics, Inc., fka MonoSol RX, LLC |
Federal Circuit |
2020-06-16 |
Denied |
Response RequestedResponse WaivedRelisted (2) |
administrative-law administrative-law-review agency-discretion appellate-jurisdiction due-process federal-circuit inter-partes-review judicial-review mandate-implementation patent patent-office sas-institute |
1. The Federal Circuit vacated three inadequate final written decisions and remanded the inter partes reviews (IPRs) with the order to implement this … |